Form 4 holding
10%+ Owner
PROVECTUS BIOPHARMACEUTICALS, INC.
- Security class
- Common Stock
- Shares / value
- 12,000,000
- Estimated value
- Report date
- 12 Aug 2024
- Price
- Ownership
- Direct
Jeffrey Allen Morris - 10%+ Owner at PROVECTUS BIOPHARMACEUTICALS, INC.
Issuer-level insider activity
- Role
- 10%+ Owner
- Issuer ticker
- PVCT on OTC
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Jeffrey Allen Morris since 12 Aug 2025
Reported holdings for Jeffrey Allen Morris in PROVECTUS BIOPHARMACEUTICALS, INC.
Form 4 holding
10%+ Owner
PROVECTUS BIOPHARMACEUTICALS, INC.
- Security class
- Common Stock
- Shares / value
- 6,500,000
- Estimated value
- Report date
- 12 Aug 2024
- Price
- Ownership
- By IRA
Form 4 holding
10%+ Owner
PROVECTUS BIOPHARMACEUTICALS, INC.
- Security class
- Series D-1 Convertible Preferred Stock
- Shares / value
- 4,260,061
- Estimated value
- Report date
- 12 Aug 2024
- Price
- Ownership
- Direct
Form 4 holding
10%+ Owner
PROVECTUS BIOPHARMACEUTICALS, INC.
- Security class
- 8% Secured Convertible Promissory Note
- Shares / value
- 244,584
- Estimated value
- Report date
- 11 Aug 2023
- Price
- Ownership
- Direct
- Underlying class
- Series D-1 Convertible Preferred Stock
- Underlying amount
Transaction history for Jeffrey Allen Morris in PROVECTUS BIOPHARMACEUTICALS, INC.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.